Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2025-12-24 @ 6:49 PM
NCT ID:
NCT04258657
Eligibility Criteria:
Inclusion Criteria:
1. pathologically diagnosed gastric adenocarcinoma
2. Type II and III esophageal-gastric-junction malignancy
3. AJCC stage II-III
4. No contraindications for surgery, radical resection can be expected
5. KPS\>60; ECOG score:0-2
6. Expactant survival period\>6 months
7. Age 20\~75
8. No other major health issues
9. Lab results within 7 days before inclusion must satisfy:
1. neutrophil≥1.5×109/L
2. PLT≥100×109/L
3. hemogloblin≥90g/L
4. ALT,AST\<1.5 upper limit
5. Tbil≤1.0×UNL
6. serum creatinine\<1.5×UNL
7. PT-INR/PTT\<1.7 upper limit
10. with measurable lesion according to RECIST1.1 criteria
11. with consent
12. co-operative
Exclusion Criteria:
1. with other major health issue
2. allergic to relevant drugs
3. experienced any other drug therapy with 4 weeks before inclusion
4. experienced any drug therapy for gastric cancer at anytime
5. diagnosed with any other malignancy within the past 5 years
6. women at child-bearing age; pregnant or breast-feeding women
7. with severe heart disease
8. with upper GI digestion or disrupted absorption
9. with peripheral neural disease
10. with transplated organs or organs having been resected for transplantation
11. known DPD deficiency
12. with uncontrolled infection
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT04258657
Study Brief:
Protocol Section:
NCT04258657